Information Provided By: 
Fly News Breaks for December 3, 2019
CURLF
Dec 3, 2019 | 07:30 EDT
Needham analyst Matt McGinley initiated coverage of Curaleaf Holdings with a Buy rating and $7.25 price target. The analyst expects the coming year to see the company transition from a period of acquisition and developmental investment to integration and operational growth, optimizing its dispensary assets in medical and adult-use legal markets across 19 states. McGinley further believes that Curaleaf can triple its revenue in 2020 while boosting its EBITDA from "modestly positive" to at least $225M.
News For CURLF From the Last 2 Days
CURLF
Apr 25, 2024 | 10:57 EDT
In this week's "Rising High," The Fly's recurring series focused on cannabis and psychedelic stock news, The Fly looks back on study dosing, a completed acquisition and a research partnership. ATAI ANNOUNCES DOSING... To see the rest of the story go to thefly.com. See Story Here
